Last reviewed · How we verify
Continued cotrimoxazole prophylaxis
Continued cotrimoxazole prophylaxis is a Small molecule drug developed by Medical Research Council. It is currently FDA-approved. Also known as: trimethoprim+sulfamethoxazole.
At a glance
| Generic name | Continued cotrimoxazole prophylaxis |
|---|---|
| Also known as | trimethoprim+sulfamethoxazole |
| Sponsor | Medical Research Council |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Antibiotics for Kidney Transplant Recipients (PHASE4)
- Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection (PHASE4)
- Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2) (PHASE3)
- Partners-based HIV Treatment for Couples Attending Antenatal Care (NA)
- Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer (PHASE3)
- Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous (PHASE4)
- Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV (PHASE2, PHASE3)
- Antibiotic Use Following Distal and Mid-shaft Hypospadias Repair (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Continued cotrimoxazole prophylaxis CI brief — competitive landscape report
- Continued cotrimoxazole prophylaxis updates RSS · CI watch RSS
- Medical Research Council portfolio CI
Frequently asked questions about Continued cotrimoxazole prophylaxis
What is Continued cotrimoxazole prophylaxis?
Continued cotrimoxazole prophylaxis is a Small molecule drug developed by Medical Research Council.
Who makes Continued cotrimoxazole prophylaxis?
Continued cotrimoxazole prophylaxis is developed and marketed by Medical Research Council (see full Medical Research Council pipeline at /company/medical-research-council).
Is Continued cotrimoxazole prophylaxis also known as anything else?
Continued cotrimoxazole prophylaxis is also known as trimethoprim+sulfamethoxazole.
What development phase is Continued cotrimoxazole prophylaxis in?
Continued cotrimoxazole prophylaxis is FDA-approved (marketed).
Related
- Manufacturer: Medical Research Council — full pipeline
- Also known as: trimethoprim+sulfamethoxazole
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing